Breaking News Headlines Today | Ground News

See every side of every news story

Arcutis Biotherapeutics image

News from Arcutis Biotherapeutics

Arcutis Biotherapeutics’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, AllSides, and Media Bias/Fact Check.

Arcutis Biotherapeutics’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Arcutis Biotherapeutics

Where is Arcutis Biotherapeutics located?Arcutis Biotherapeutics's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Arcutis Biotherapeutics News

Arcutis Announces Positive Topline Results for INTEGUMENT-INFANT Phase 2 Trial of ZORYVE® ...

Arcutis Announces Positive Topline Results for INTEGUMENT-INFANT Phase 2 Trial of ZORYVE® ...

100% Left coverage: 1 sources

58% of participants achieved a 75% improvement in Eczema Area and Severity Index (EASI-75) with ZORYVE cream 0.05% at Week 4Investigational ZORYVE cream 0.05% was well tolerated and demonstrated a safety profile consistent with previous studies, with no new safety…See the Story

Arcutis Biotherapeutics, Inc. Announces Termination of Promotion Agreement with Kowa

Westlake Village · Westlake Village

Arcutis Biotherapeutics, Inc. Announces Termination of Promotion Agreement with Kowa

100% Right coverage: 1 sources

WESTLAKE VILLAGE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing...See the Story

Nationwide Survey Underscores Concerns with Use of Topical Steroids and Need for Long-Term ...

United States · United States

Nationwide Survey Underscores Concerns with Use of Topical Steroids and Need for Long-Term ...

100% Center coverage: 1 sources

Nearly 9 in 10 adults and parents of children with plaque psoriasis, atopic dermatitis, and seborrheic dermatitis being treated with topical steroids are concerned about side effectsNearly 8 in 10 adults and parents agreed that their or their child's treatment…See the Story